Companies › AUTL
AUTOLUS THERAPEUTICS LTD (AUTL)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001730463 · EDGAR filings · Updated 2026-07-01
AUTOLUS THERAPEUTICS LTD (AUTL) has reported institutional ownership of 50.5%, with 84 institutional managers holding positions valued at $184.4M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, AUTOLUS THERAPEUTICS LTD has 84 institutional holders and institutional ownership of 50.5%.
Insider activity
Insiders reported 0 transactions (0 buys, 0 sells) across 4 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
ALX ONCOLOGY HLDGS INC (ALXO) · EVOLUS INC (EOLS) · ARCTURUS THERAPEUTICS HLDGS (ARCT) · SIGA TECHNOLOGIES INC (SIGA) · USANA HEALTH SCIENCES INC (USNA) · ANIKA THERAPEUTICS INC (ANIK)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-01.